Review



trough pellet receptacle  (Med Associates Inc)


Bioz Verified Symbol Med Associates Inc is a verified supplier
Bioz Manufacturer Symbol Med Associates Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    Med Associates Inc trough pellet receptacle
    Trough Pellet Receptacle, supplied by Med Associates Inc, used in various techniques. Bioz Stars score: 97/100, based on 6557 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/trough pellet receptacle/product/Med Associates Inc
    Average 97 stars, based on 6557 article reviews
    trough pellet receptacle - by Bioz Stars, 2026-06
    97/100 stars

    Images



    Similar Products

    97
    Med Associates Inc trough pellet receptacle
    Trough Pellet Receptacle, supplied by Med Associates Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/trough pellet receptacle/product/Med Associates Inc
    Average 97 stars, based on 1 article reviews
    trough pellet receptacle - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    97
    Med Associates Inc ventilation fan
    Ventilation Fan, supplied by Med Associates Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ventilation fan/product/Med Associates Inc
    Average 97 stars, based on 1 article reviews
    ventilation fan - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    97
    Med Associates Inc mouse operant self administration chambers
    Complete experimental protocol of our mouse model of operant WIN 55,212–2 <t>intravenous</t> <t>self-administration</t>
    Mouse Operant Self Administration Chambers, supplied by Med Associates Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse operant self administration chambers/product/Med Associates Inc
    Average 97 stars, based on 1 article reviews
    mouse operant self administration chambers - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    97
    Med Associates Inc lux meter
    Complete experimental protocol of our mouse model of operant WIN 55,212–2 <t>intravenous</t> <t>self-administration</t>
    Lux Meter, supplied by Med Associates Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lux meter/product/Med Associates Inc
    Average 97 stars, based on 1 article reviews
    lux meter - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    97
    Med Associates Inc sound pressure level measurement package
    Complete experimental protocol of our mouse model of operant WIN 55,212–2 <t>intravenous</t> <t>self-administration</t>
    Sound Pressure Level Measurement Package, supplied by Med Associates Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sound pressure level measurement package/product/Med Associates Inc
    Average 97 stars, based on 1 article reviews
    sound pressure level measurement package - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    97
    Med Associates Inc modular chamber
    Complete experimental protocol of our mouse model of operant WIN 55,212–2 <t>intravenous</t> <t>self-administration</t>
    Modular Chamber, supplied by Med Associates Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/modular chamber/product/Med Associates Inc
    Average 97 stars, based on 1 article reviews
    modular chamber - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    97
    Med Associates Inc grid floor
    Complete experimental protocol of our mouse model of operant WIN 55,212–2 <t>intravenous</t> <t>self-administration</t>
    Grid Floor, supplied by Med Associates Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/grid floor/product/Med Associates Inc
    Average 97 stars, based on 1 article reviews
    grid floor - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    Image Search Results


    Complete experimental protocol of our mouse model of operant WIN 55,212–2 intravenous self-administration

    Journal: Bio-protocol

    Article Title: A Male Mouse Model of WIN 55,212–2 Self-Administration to Study Cannabinoid Addiction

    doi: 10.21769/BioProtoc.5652

    Figure Lengend Snippet: Complete experimental protocol of our mouse model of operant WIN 55,212–2 intravenous self-administration

    Article Snippet: Mouse operant self-administration chambers (Med Associates, model: ENV-307A-CT) Operant chambers are equipped with two nose-poke holes (holes of 1.2 cm diameter), one randomly selected as the active nose poke and the other as the inactive.

    Techniques:

    An intraperitoneal injection of WIN 55,212-2 (0.1 mg/kg) is administered 24 h before the first self-administration session to minimize the aversive effects of the initial cannabinoid exposure. During the first week of operant training, mice acquire WIN 55,212-2 self-administration under fixed-ratio (FR) schedules, with 5 sessions at FR1 followed by 5 sessions at FR2. Sessions 1–10 and 12 include a 15-min drug-free period (DFP), but only the latest 8–10 sessions are used to quantify persistence of responding, the first addiction-like criterion. In session 11, motivation for WIN 55,212-2 is assessed using a progressive-ratio (PR) schedule, providing the second criterion. FR2 session is then re-established in session 12 to stabilize responding before punishment testing. In session 13, compulsivity-like behavior is evaluated in a foot-shock punishment test, yielding the third diagnostic criterion and allowing classification of mice as addicted or non-addicted. Extinction training is conducted in sessions 14–23, and in session 24, a cue-induced reinstatement test is performed to probe relapse-like drug seeking and obtain the parameters related to craving.

    Journal: Bio-protocol

    Article Title: A Male Mouse Model of WIN 55,212–2 Self-Administration to Study Cannabinoid Addiction

    doi: 10.21769/BioProtoc.5652

    Figure Lengend Snippet: An intraperitoneal injection of WIN 55,212-2 (0.1 mg/kg) is administered 24 h before the first self-administration session to minimize the aversive effects of the initial cannabinoid exposure. During the first week of operant training, mice acquire WIN 55,212-2 self-administration under fixed-ratio (FR) schedules, with 5 sessions at FR1 followed by 5 sessions at FR2. Sessions 1–10 and 12 include a 15-min drug-free period (DFP), but only the latest 8–10 sessions are used to quantify persistence of responding, the first addiction-like criterion. In session 11, motivation for WIN 55,212-2 is assessed using a progressive-ratio (PR) schedule, providing the second criterion. FR2 session is then re-established in session 12 to stabilize responding before punishment testing. In session 13, compulsivity-like behavior is evaluated in a foot-shock punishment test, yielding the third diagnostic criterion and allowing classification of mice as addicted or non-addicted. Extinction training is conducted in sessions 14–23, and in session 24, a cue-induced reinstatement test is performed to probe relapse-like drug seeking and obtain the parameters related to craving.

    Article Snippet: Mouse operant self-administration chambers (Med Associates, model: ENV-307A-CT) Operant chambers are equipped with two nose-poke holes (holes of 1.2 cm diameter), one randomly selected as the active nose poke and the other as the inactive.

    Techniques: Injection, Diagnostic Assay

    Persistence was defined as non-reinforced active responses during the 15-min drug-free period across three days before the progressive-ratio (PR) session. Only the operant box house light is on during this period. Motivation was assessed with a PR schedule, with the breakpoint (last ratio completed before cessation of responding) taken as the motivation value. Only the conditioned-stimulus cue light and the drug delivery were active. Compulsivity was measured in a 50-min punished self-administration session under FR2, during which each infusion was paired with a 0.18 mA, 2 s foot shock, and the total number of shocks indexed resistance to punishment. The conditioned-stimulus cue light, the drug delivery, and the unconditioned stimulus of the grid floor delivering foot shocks were active. An overall addiction score was derived from these three behavioral measures.

    Journal: Bio-protocol

    Article Title: A Male Mouse Model of WIN 55,212–2 Self-Administration to Study Cannabinoid Addiction

    doi: 10.21769/BioProtoc.5652

    Figure Lengend Snippet: Persistence was defined as non-reinforced active responses during the 15-min drug-free period across three days before the progressive-ratio (PR) session. Only the operant box house light is on during this period. Motivation was assessed with a PR schedule, with the breakpoint (last ratio completed before cessation of responding) taken as the motivation value. Only the conditioned-stimulus cue light and the drug delivery were active. Compulsivity was measured in a 50-min punished self-administration session under FR2, during which each infusion was paired with a 0.18 mA, 2 s foot shock, and the total number of shocks indexed resistance to punishment. The conditioned-stimulus cue light, the drug delivery, and the unconditioned stimulus of the grid floor delivering foot shocks were active. An overall addiction score was derived from these three behavioral measures.

    Article Snippet: Mouse operant self-administration chambers (Med Associates, model: ENV-307A-CT) Operant chambers are equipped with two nose-poke holes (holes of 1.2 cm diameter), one randomly selected as the active nose poke and the other as the inactive.

    Techniques: Derivative Assay

    Impulsivity-like behavior was quantified as the number of non-reinforced active responses emitted during the 10-s time-out period following each WIN 55,212-2 infusion, averaged across the 3 days preceding the progressive-ratio (PR) test (higher counts indicate greater difficulty inhibiting responding once initiated). Sensitivity to reward was assessed as the total number of reinforcers earned during 2-h sessions across the last three consecutive FR2 self-administration sessions maintained by WIN 55,212-2, with higher reinforcer counts reflecting greater reward sensitivity.

    Journal: Bio-protocol

    Article Title: A Male Mouse Model of WIN 55,212–2 Self-Administration to Study Cannabinoid Addiction

    doi: 10.21769/BioProtoc.5652

    Figure Lengend Snippet: Impulsivity-like behavior was quantified as the number of non-reinforced active responses emitted during the 10-s time-out period following each WIN 55,212-2 infusion, averaged across the 3 days preceding the progressive-ratio (PR) test (higher counts indicate greater difficulty inhibiting responding once initiated). Sensitivity to reward was assessed as the total number of reinforcers earned during 2-h sessions across the last three consecutive FR2 self-administration sessions maintained by WIN 55,212-2, with higher reinforcer counts reflecting greater reward sensitivity.

    Article Snippet: Mouse operant self-administration chambers (Med Associates, model: ENV-307A-CT) Operant chambers are equipped with two nose-poke holes (holes of 1.2 cm diameter), one randomly selected as the active nose poke and the other as the inactive.

    Techniques:

    Number of total active and inactive nose pokes performed by CNO- and saline-treated groups obtained during 2 h of operant self-administration maintained by intravenous infusions of WIN 55,212-2 in both FR1 and FR2 schedules of reinforcement (mean ± S.E.M., repeated measures ANOVA). Data derived from Cajiao et al., 2023 [7].

    Journal: Bio-protocol

    Article Title: A Male Mouse Model of WIN 55,212–2 Self-Administration to Study Cannabinoid Addiction

    doi: 10.21769/BioProtoc.5652

    Figure Lengend Snippet: Number of total active and inactive nose pokes performed by CNO- and saline-treated groups obtained during 2 h of operant self-administration maintained by intravenous infusions of WIN 55,212-2 in both FR1 and FR2 schedules of reinforcement (mean ± S.E.M., repeated measures ANOVA). Data derived from Cajiao et al., 2023 [7].

    Article Snippet: Mouse operant self-administration chambers (Med Associates, model: ENV-307A-CT) Operant chambers are equipped with two nose-poke holes (holes of 1.2 cm diameter), one randomly selected as the active nose poke and the other as the inactive.

    Techniques: Saline, Derivative Assay